Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.

作者: Marta Barrachina , Esther Castaño , Esther Dalfó , Tamara Maes , Carlos Buesa

DOI: 10.1016/J.NBD.2005.11.005

关键词:

摘要: Parkinson disease (PD) and dementia with Lewy bodies (DLB) are characterized by the accumulation of abnormal alpha-synuclein ubiquitin in protein aggregates conforming neurites. Ubiquitin C-terminal hydrolase-1 (UCHL-1) disassembles polyubiquitin chains to increase availability free monomeric proteasome system (UPS) thus favoring degradation. Since mutations UCHL-1 gene, reducing UPS activity 50%, have been reported autosomal dominant PD, inhibition results formation mesencephalic cultured neurons, present study was initiated test mRNA levels post-mortem frontal cortex (area 8) PD DLB cases, compared age-matched controls. TaqMan PCR assays, Western blots demonstrated down-regulation cerebral (either pure forms, not associated Alzheimer disease: AD, common accompanying AD changes), but when Interestingly, expressions were reduced medulla oblongata same cases. Moreover, decreased substantia nigra cases body pathology. several proteasomal subunits, including 20SX, 20SY, 19S 11Salpha. Yet UCHL-3 expression patients. Together, these observations show as a contributory factor aggregation DLB, points putative therapeutic target treatment DLB.

参考文章(51)
Kazumasa Saigoh, Yu-Lai Wang, Jun-Gyo Suh, Toshiyuki Yamanishi, Yoshihisa Sakai, Hidenori Kiyosawa, Takayuki Harada, Nobutsune Ichihara, Shigeharu Wakana, Tateki Kikuchi, Keiji Wada, Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nature Genetics. ,vol. 23, pp. 47- 51 ,(1999) , 10.1038/12647
Kevin St P. McNaught, Catherine Mytilineou, Ruth JnoBaptiste, Jocelyn Yabut, P. Shashidharan, Peter Jenner, C. Warren Olanow, Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures Journal of Neurochemistry. ,vol. 81, pp. 301- 306 ,(2002) , 10.1046/J.1471-4159.2002.00821.X
Paul Ince, Dementia with Lewy Bodies Advances in Experimental Medicine and Biology. ,vol. 487, pp. 135- 145 ,(2001) , 10.1007/978-1-4615-1249-3_12
Keiji Tanaka, Chizuko Tsurumi, The 26S proteasome: subunits and functions Molecular Biology Reports. ,vol. 24, pp. 3- 11 ,(1997) , 10.1023/A:1006876904158
Elisabeth Leroy, Rebecca Boyer, Georg Auburger, Barbara Leube, Gudrun Ulm, Eva Mezey, Gyongyi Harta, Michael J. Brownstein, Sobhanadditya Jonnalagada, Tanya Chernova, Anindya Dehejia, Christian Lavedan, Thomas Gasser, Peter J. Steinbach, Keith D. Wilkinson, Mihael H. Polymeropoulos, The ubiquitin pathway in Parkinson's disease Nature. ,vol. 395, pp. 451- 452 ,(1998) , 10.1038/26652
Z Zachar, D Garza, T B Chou, J Goland, P M Bingham, Molecular cloning and genetic analysis of the suppressor-of-white-apricot locus from Drosophila melanogaster. Molecular and Cellular Biology. ,vol. 7, pp. 2498- 2505 ,(1987) , 10.1128/MCB.7.7.2498
K. Wilkinson, K. Lee, S Deshpande, P Duerksen-Hughes, J. Boss, J Pohl, The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase Science. ,vol. 246, pp. 670- 673 ,(1989) , 10.1126/SCIENCE.2530630
K. ODA, K. YAMAZAKIT, H. MIURA, H. SHIBASAKI, T. KIKUCHI, Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse. Neuropathology and Applied Neurobiology. ,vol. 18, pp. 265- 281 ,(1992) , 10.1111/J.1365-2990.1992.TB00789.X
Kaori Nishikawa, Hang Li, Ryoichi Kawamura, Hitoshi Osaka, Yu-Lai Wang, Yoko Hara, Takatsugu Hirokawa, Yoshimasa Manago, Taiju Amano, Mami Noda, Shunsuke Aoki, Keiji Wada, Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochemical and Biophysical Research Communications. ,vol. 304, pp. 176- 183 ,(2003) , 10.1016/S0006-291X(03)00555-2
Jun Li, Martin Rechsteiner, Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie. ,vol. 83, pp. 373- 383 ,(2001) , 10.1016/S0300-9084(01)01236-6